ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD

Clinical trial NCT00801684 · COMPLETED

Trial details

NCT number: NCT00801684
Sponsor: Alkermes, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2009-02-01
Primary completion: 2009-04-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.